Imafuku, Shinichi <br/><br/>
Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study.  [electronic resource] 

 -  The Journal of dermatology  Sep 2016 
 - 1011-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1346-8138 
<br/><br/><label>Standard No.: </label>10.1111/1346-8138.13306  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Arthralgia--chemically induced<br/>Diabetes Mellitus--chemically induced<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Interleukin-17--antagonists & inhibitors<br/>Japan<br/>Male<br/>Middle Aged<br/>Nasopharyngitis--chemically induced<br/>Practice Guidelines as Topic<br/>Psoriasis--drug therapy<br/>Severity of Illness Index<br/>Treatment Outcome<br/>Urticaria--chemically induced